Talon Therapeutics' Marqibo(R) (vinCRIStine sulfate LIPOSOME injection) Granted Accelerated Approval by FDA

SOUTH SAN FRANCISCO, Calif. — Talon Therapeutics today announced Marqibo(R) (vinCRIStine sulfate LIPOSOME injection) received accelerated approval from the U.S. Food and Drug Administration (FDA) for …

Powered by WPeMatico